Charles Masson’s practice focuses on private equity transactions, and he has deep experience advising on complex M&A transactions.

Charles also regularly advises limited partners and general partners as part of fund formation processes – primary commitments, GP/LP partnerships, corporate/GP partnerships, secondary transfers, co-investments, consortium agreements, etc.

Charles joined the firm in 2006 and became a partner in 2014.

Read More

Notable Experience

Private Equity

  • Latour Capital in connection with several recent acquisitions, including:

    • the privatisation of Systra 
    • its acquisition of Gutor from Schneider
    • its investment in Funecap
    • its acquisition of Omni Pac Group from Motion Equity Partners
    • its acquisition of Santiane from BlackFin Capital Partners
    • its acquisition of Solvay’s peroxide businesses

  • Sienna Investment Managers in connection with the acquisitions of private debt manager Acofi from its founders, its purchase of real estate specialist l’Etoile Properties, its joint venture with Malakoff Humanis and its acquisition of 100% of Ver Capital.

  • Bridgepoint in its investment in Younited Credit and in connection with the combination of Younited Credit with Iris Financial and its resulting IPO on Euronext Amsterdam and Euronext Paris.

  • Bridgepoint in its acquisition of Vivacy.

  • Apollo Funds in the acquisition of Ingenico from Worldline.

  • Mubadala Capital in connection with the sale of the Looping Group to PAI Partners.

  • De Agostini in connection with the acquisition of the Endemol Shine Group by Banijay Group, and in relation to the merger between Zodiak and Banijay, creating the world’s largest independent media production and distribution company.

  • Hopu Investments in connection with its investment in Ceva Santé Animale.

  • Latour Capital and Bpifrance in the consortium acquisition of the Environment Division of Plastic Omnium (now Sulo) and subsequent acquisition by Sulo of San Sac.

  • Bridgepoint in the sale of portfolio company Médipôle Partenaires to Elsan, creating the leader in French private health care.

  • Warburg Pincus and Consolidated Precision Products Corp. (CPP) in CPP’s recapitalization.

  • Warburg Pincus in its acquisition of Sundyne from Carlyle Group and BC Partners.

  • Emerging Capital Partners in numerous investments and exits over the years, including in its exit sale of Oragroup to IPS-CCRAE, in Atlas Bottling Corporation, PepsiCo’s exclusive bottler in Algeria, and in Oragroup, head company of the Orabank network.

  • Bridgepoint and Eurazeo in their consortium acquisition of Foncia.

See More

M&A

  • Alstom in the transfer of all of its interests in energy joint ventures to General Electric for €2.59 billion; and in its proposed €15 billion strategic combination with Siemens.

  • Lafarge in several M&A transactions, including the divestment by competitive process of €6.5 billion of assets as part of regulatory approval requirements for its merger with Holcim.

  • Hanesbrands in its €400 million acquisition of DBApparel from Sun Capital Partners.

  • Total in the sale of its fertilizer business to Borealis.

  • Groupama in the sales of GAN Eurocourtage to Allianz and of Groupama Transport to Helvetia.

  • International Finance Corporation in the sale to Veolia Eau of stakes held by it in certain subsidiaries of Veolia Eau.

See More

Fund Formation

  • Electricité de France in the creation of Amundi Energy Transition (AET), the asset management company jointly owned by Amundi and EDF; and in the creation of Electranova Capital, a fund managed by Idinvest.

  • Natixis Private Equity in the secondary sale of limited partnership interests in various investment funds.

  • Two large family offices in connection with several direct and indirect investments and co-investments.

  • Several LPs in their structuring of single asset funds, multi-funds investments, and partnerships with GPs.

See More

Publications